v3.26.1
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Noncontrolling interest
Beginning balance (in shares) at Dec. 31, 2024   191,778,639      
Beginning balance at Dec. 31, 2024 $ 100,955 $ 192 $ 1,107,952 $ (1,008,293) $ 1,104
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) 6,299     6,553 (254)
Issuance of common stock upon vesting of restricted stock units (in shares)   6,056,296      
Forfeitures (in shares)   (277)      
Equity-based compensation 32,740 $ 6 32,734    
Stock options exercised (in shares)   123,579      
Stock options exercised 1,823   1,823    
Sale of consolidated subsidiary (850)       (850)
Ending balance (in shares) at Jun. 30, 2025   197,958,237      
Ending balance at Jun. 30, 2025 140,967 $ 198 1,142,509 (1,001,740) 0
Beginning balance (in shares) at Mar. 31, 2025   197,667,653      
Beginning balance at Mar. 31, 2025 108,995 $ 198 1,125,340 (1,017,407) 864
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) 15,653     15,667 (14)
Issuance of common stock upon vesting of restricted stock units (in shares)   191,477      
Equity-based compensation 15,553 $ 0 15,553    
Stock options exercised (in shares)   99,107      
Stock options exercised 1,616   1,616    
Sale of consolidated subsidiary (850)       (850)
Ending balance (in shares) at Jun. 30, 2025   197,958,237      
Ending balance at Jun. 30, 2025 $ 140,967 $ 198 1,142,509 (1,001,740) 0
Beginning balance (in shares) at Dec. 31, 2025 204,153,619 204,153,619      
Beginning balance at Dec. 31, 2025 $ 179,277 $ 205 1,188,089 (1,009,017) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock options exercised (in shares) 137,087        
Ending balance (in shares) at Mar. 31, 2026   206,671,068      
Ending balance at Mar. 31, 2026 $ 206,885 $ 207 1,204,279 (997,601) 0
Beginning balance (in shares) at Dec. 31, 2025 204,153,619 204,153,619      
Beginning balance at Dec. 31, 2025 $ 179,277 $ 205 1,188,089 (1,009,017) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) 47,976     47,976  
Issuance of common stock upon vesting of restricted stock units (in shares)   2,655,815      
Equity-based compensation 32,193 $ 2 32,191    
Stock options exercised (in shares)   368,759      
Stock options exercised $ 5,685   5,685    
Ending balance (in shares) at Jun. 30, 2026 207,178,193 207,178,193      
Ending balance at Jun. 30, 2026 $ 265,131 $ 207 1,225,965 (961,041) 0
Beginning balance (in shares) at Mar. 31, 2026   206,671,068      
Beginning balance at Mar. 31, 2026 206,885 $ 207 1,204,279 (997,601) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income (loss) 36,560     36,560  
Issuance of common stock upon vesting of restricted stock units (in shares)   275,453      
Equity-based compensation $ 18,174 $ 0 18,174    
Stock options exercised (in shares) 231,672 231,672      
Stock options exercised $ 3,512   3,512    
Ending balance (in shares) at Jun. 30, 2026 207,178,193 207,178,193      
Ending balance at Jun. 30, 2026 $ 265,131 $ 207 $ 1,225,965 $ (961,041) $ 0